|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.91 USD | +5.68% |
|
+7.03% | +26.12% |
| Apr. 24 | Health Care Down Amid Mixed Earnings -- Health Care Roundup | DJ |
| Apr. 24 | Wall St edges lower as rising yields overshadow upbeat corporate results | RE |
Oct 28 (Reuters) - Boston Scientific Corp reported a third-quarter loss on Wednesday, hurt by lower demand for its medical devices.
Net loss attributable to Boston Scientific was $169 million, or 12 cents per share, in the quarter ended Sept 30, compared with net earnings of $126 million, or 9 cents per share, last year.
(Reporting by Trisha Roy and Mrinalika Roy in Bengaluru)
| 1st Jan change | Capi. | |
|---|---|---|
| +26.12% | 101B | |
| +8.78% | 219B | |
| +8.24% | 187B | |
| +11.16% | 134B | |
| +0.30% | 62.27B | |
| +16.21% | 52.82B | |
| -1.63% | 47.49B | |
| -1.11% | 40.79B | |
| +12.16% | 39.35B | |
| +6.84% | 27.06B |
BOSTON SCIENTIFIC CORPORATION 
